Materials and Methods

Materials
Thermal Stability Studies
Accelerated thermal stability of SP3-07. Aliquots of the SLRM, SP3-07, were received in 1-mL glass containers from Behringwerke.
They were thawed from storage (-70#{176}C) by allowing the samples to come to room temperature. The samples were gently mixed for 30 mm and then kept at five temperatures (4, 25, 37, 45, and 55#{176}C) for 3 weeks. Experimental samples were removed at intervals on designated days throughout this period. Each sample was labeled, divided into aliquots, and stored in 4-mL glass vials (Wheaton, Millville, NJ) at -70#{176}C. Control samples were thawed to room temperature and refrozen at -70#{176}C. On the day of analysis, all experimental samples and controls, including a zero time sample that was stored frozen, were removed from storage and warmed to room temperature.
The Resufts Stability studies with SP3-07. The ape B concentration in SP3-07 was immunologically stable when stored at -70#{176}C. As shown in Fig. 1 We measured by RIA the ape B concentration in SP3-07 samples exposed to increased temperatures over a 3-week period and subjected the resulting data to the classical Arrhenius analysis to determine stability (15).
A series of plots was generated
for the log relative concentration vs the age of the samples (in days) for the temperatures indicated.
The data for samples stored at 55#{176}C for 6 or more days were omitted for theirnonlinearity, possibly because of protein degradation.
The absolute value of the slope vs temperature was modeled with data for samples stored at 25-45#{176}C. The estimated slope for samples stored at 4#{176}C was not used because the experimental data did not show a significant change in negative slope (Table 1) .
From the RIA data used to generate Arrhenius plots (secondary slope vs temperature), we predicted that, if the reference material were stored at 25#{176}C, in 21 days 10% of the ape B in the reference material would degrade. This prediction agreed closely with the observed peratures, analyzed by RIA; they-axis shows the ratio of the result for an experimental sample divided by the result for a control sample that had been thawed and refrozen one time. RIA of the ape A-I concentration in the thermally aged SP3-07 showed degradation similar to that seen for ape B measured by RIA; however, the ape A-I in SP3-07 was stable at 4-45#{176}C for 1 week before marked degradation was detected (Fig. 2B) . Both RID and the monoclonal antibody-based ELISA showed similar patterns of ape B degradation for samples stored at 4, 45, and 55#{176}C (data not shown).
We also used liquid immunoprecipitation assays to analyze the ape B content of the thermally aged SP3-07. Fixed-time INA of these samples showed ape B to be stable at 4#{176}C over the duration of the experiment (Fig.  3A) . At higher temperatures (25, 37, or 45#{176}C), the ape B concentration apparently increased by 5-10% after 1 day (Fig. 3A) . At 55#{176}C, the ape B concentration decreased rapidly after 7 days, with the samples exposed >7 days identified as turbid by the INA instrument. End-point INA of these same samples showed patterns 2 of ape B degradation similar to patterns found by fixedtime INA of thermally aged SP3-07. In a previous international investigation, the role of anti-apelipeprotein antiserum was studied to evaluate the contribution of these antisera to the variance of among-laboratory measurements (19) . We wished to test the role of different pelyclonal antiserum preparations as a possible explanation for the differences in results between RIA and the INA methods. When undiluted, pelyclonal goat antiape B antiserum (prepared in-house) was substituted for the polyclonal antiserum provided by the manufacturer in both fixed-time and end-point INA, we observed patterns similar to fixed-time INA with commercial antiserum, and only slight differences in slopes. Fixed-time INA analysis of ape A-I in the thermally aged SP3-07 showed degradation curves similar to those seen for RIA (Fig. 3B) .
End-point ITA analysis of SP3-07 for ape B showed trends similar to those found with fixed-time and endpoint INA The relative concentrations of experimental samples kept at 4#{176}C were stable (with a slightpositive slope), experimental samples kept at 25 and 45#{176}C had measured ape B concentrations higher than those of the control, and the ape B concentration of experimental samples stored at 55#{176}C began to decline after 5 days and dropped off considerably after 2 weeks (data not shown).
Results of the analysis of ape A-I in SP3-07 by ITA were similar to those by fixed-time INA (Fig. 3B) . Rate nephelometric analysis of SP3-07 showed that the ape B content in the samples stored at 4#{176}C degraded by -10% over the first week of exposure to increased temperature, and then stabilized (data not shown). Temporal thermal stability of SP3-07. We investigated the temporal thermal stability of SP3-07, using both RJA and fixed-time INA. According to the RIA, SP3-07 lost >5% of the measurable ape B over a 3-month period when stored at 4#{176}C, a pattern that continued for the next several measurement intervals (Fig.  4) ; at 25#{176}C, the material was stable for 1 month, but it began to degrade after 2 months and lost -45% of its initial ape B concentration by the end of the study. However, when fixed-time INA was used to determine the ape B concentration of the same thermally aged samples, the ape B concentration appeared to increase; at 4#{176}C, the material was stable for 2 months but showed a slight increase over the duration of the 10-month experiment; and at 25#{176}C, the measurable ape B concentration increased by as much as 60% (Fig. 4) . that the concentration of ape B in the reference material remained constant for at least 1 year stored at -70#{176}C, and that -10% of the ape B immunoreactive material was lost when stored at 4#{176}C for 10 months. We first used fixed-time INA to measure the concentrations of ape B in the thermally treated samples and found that results were greater than those we initially obtained for SP3-07 samples stored at -70#{176}C. Upon analyzing the same samples by RIA, we saw the decrease in ape B content that we had predicted for a protein material exposed to denaturing conditions. Because SP3-07 has been proposed for use as an international primary standard
for immunological tests, we tested the stability of the material with regard to other commonly used methods (RID, ELISA, ITA).
Using several analytical techniques to measure the degradation of apolipoproteins in SP3-07, we illustrated method-related differences in the measurements. We found a similar type of degradation with any of several immunochemical methods (RIA, ELISA, and RID). As determined by RIA measurements, the ape B in SP3-07 remained stable for as long as 3 weeks at 25#{176}C, and lost 10% over 10 months at 4#{176}C. Because the ape B concentrations in aged samples measured by fixed-time INA were higher than initial values, we also investigated ape A-I contents of the SLRM samples used for the accelerated stability study. Both RIA and fixed-time INA showed temperature-dependent degradation of ape A-I in the liquid material, in contrast to the stability shown by the lyophilized ape A-I reference material, SP1-Ol, even at increased temperatures (6). The stability of ape A-I in SP3-07 was studied only as a qualitative control (as another apelipeprotein component) for some of the analytical methods used in the ape B stability studies.
Fresh serum samples held for 3 weeks at temperatures ranging from 4 to 45#{176}C also showed ape B degradation within this period when measured by RIA, but not by fixed-time INA The contents of the samples remained stable for 3 days at 4#{176}C. This difference between the reference material and fresh serum is probably attributable to the stabilizing agents added to SP3-
07.
When we used ELISA to analyze aged SP3-07 samples, the ape B degradation exceeded that seen by RIA. This phenomenon was possibly due to the fact that the monoclonal antibody conjugate used in the assay was selected for a single epitope on the ape B molecule, which is less stable than the pelyclonal antiserum used in RIA (22 (17, 18 
